Jounce Therapeutics Competitors and Similar CompaniesClear all

Jounce Therapeutics's competitors and similar companies include Lyell, Triumvira, Immunai, Seagen and MetaStat.

	Jounce Therapeutics Jounce Therapeutics is a clinical-stage immunotherapy company.	Lyell Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.	Triumvira Triumvira Immunologics is an immunotherapy company.	Immunai Immunai is a biotechnology company specializing in immune cell data analysis for drug development.	Seagen Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer.	MetaStat MetaStat, Inc. develops and commercializes diagnostic tests for risk of cancer metastasis, companion diagnostics and anti-metastatic drugs.
Founding Date	Founding Date 2013	Founding Date 2018	Founding Date 2015	Founding Date 2018	Founding Date 1998	Founding Date 2010
Type	Type Public	Type Public	Type Private	Type Private	Type Subsidiary	Type Public
Tags	Tags Healthcare Technology healthtech oncology platform therapy	Tags Healthcare biotech oncology platform therapy	Tags Healthcare biotech drug development life sciences pharma therapy	Tags Healthcare biotech clinical research machine learning oncology platform	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech drug development oncology therapy
Locations	Locations Cambridge, US HQ	Locations South San Francisco, US HQ Bothell, US Seattle, US	Locations Austin, US HQ Hamilton, CA	Locations New York, US HQ Prague, CZ Ness Ziona, IL Tel Aviv, IL Zurich, CH	Locations Bothell, US HQ Mississauga, CA Hørsholm, DK Rueil Malmaison, FR München, DE Milano, IT Schiphol, NL see more	Locations Boston, US HQ
Employees	Employees 1302% increase	Employees 188	Employees 287% decrease	Employees 1873% increase	Employees 3,25622% increase	Employees 6
Valuation ($)	Valuation ($) 101.6 m	Valuation ($) 243.3 m	Valuation ($) N/A	Valuation ($) 1.2 b	Valuation ($) N/A	Valuation ($) 20.6 k
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $36k (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $2b (FY, 2022)	Revenue (est.) $23.3k (FY, 2018)
Net income	Net income ($50.9m) (FY, 2022)	Net income ($274.4m) (FY, 2025)	Net income N/A	Net income N/A	Net income ($610.3m) (FY, 2022)	Net income ($3.2m) (FY, 2018)
Funding
Latest funding round	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 55m (almost 6 years ago)	Latest funding round $ 215m (over 4 years ago)	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised $ 103m	Total funding raised N/A	Total funding raised $ 55m	Total funding raised $ 295m	Total funding raised $ 164m	Total funding raised $ 350k